Pacmilimab (Anti-B7-H1 / PD-L1 / CD274)

Pacmilimab (anti-B7-H1 / PD-L1 / CD274) is a monoclonal antibody directed against the tumor-associated antigen (TAA) programmed cell death 1 ligand 1 (PD-L1; B7-H1; CD274) with potential immune checkpoint inhibitory and antineoplastic activities. MW: 152.6 kD.

• Supplier: Selleck Chemicals
• Product #: A2781
• Sku #: A2781-1mg